Clinical Trials Logo

Clinical Trial Summary

An arteriovenous (AV) fistula is essential for patients with kidney failure on dialysis. There is no clear data on the best method to create a new brachial basilic AV fistula (BBAVF), so the choice between a single procedure and two separate procedures is left to the surgeon. Both approaches are standard care. This study aims to compare patient-centered outcomes and quality of life by randomly assigning patients needing a BBAVF to either a one-stage or two-stage procedure.


Clinical Trial Description

The aim of the pilot trial is to compare the outcomes of patients with end stage kidney failure (ESKD) who are candidates for a new brachial basilic arteriovenous fistula (BBAVF). Patients will be randomized to either one-stage or two-stage BBAVF procedure, both standard of care for creating BBAVF. The main outcome will be primary clinical functional patency, defined as successful use of BBAVF over a continuous 4-week period without any need for additional procedure on the BBAVF. The secondary outcomes are fistula-related complications, duration of central venous catheter (CVC) for those on dialysis, and quality of life (QoL) measures. The study hypothesizes that the primary patency will be superior following the two-stage BBAVF procedure compare to one-stage procedure. However, CVC-related complications are expected to be higher following the two-stage procedure compared to the one-stage procedure. Patient will be followed for a minimum duration of 12-months per subject. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04376567
Study type Interventional
Source University of Arizona
Contact
Status Active, not recruiting
Phase N/A
Start date October 1, 2021
Completion date October 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT03952819 - The Effects of Hemodialysis on Serum Sclerostin Levels
Active, not recruiting NCT04054128 - Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients Phase 4
Recruiting NCT06034691 - Exploratory Research of PCSK9 Inhibitor on Patency of aAVF After PTA With PCB N/A
Completed NCT03627884 - Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation Phase 4
Recruiting NCT06001827 - SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study N/A
Recruiting NCT04285073 - Prospective, Multicenter, Non-randomized, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of e-PTFE Grafts Inner Surface-treated With Paclitaxel as an Access for Hemodialysis in Patients With End-stage Renal Disease. N/A
Recruiting NCT05906550 - Flow Dysfunction of Hemodialysis Vascular Access N/A
Not yet recruiting NCT04098159 - Role of Regular Surveillance on Maintenance of Patency of an Arteriovenous Access N/A
Terminated NCT05228132 - The Pristine Post-Market Study N/A
Recruiting NCT03365089 - Collateral Ligation in Failing Fistulas N/A
Recruiting NCT04489849 - Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access Phase 4
Recruiting NCT03140345 - Integrative HD Vascular Access Assessment N/A
Enrolling by invitation NCT04381754 - Use of Implanting the Biotronik Passeo-18 Lux Drug Coated Balloon to Treat Failing Haemodialysis Arteriovenous Fistulas and Grafts.
Completed NCT03988270 - Prefistula Forearm Exercise in Pts Requiring Chronic HD Therapy N/A
Recruiting NCT04502160 - The Northern Ireland Haemodialysis Vascular Access Database
Active, not recruiting NCT05418816 - SelfWrap-Assisted Arteriovenous Fistulas N/A
Completed NCT04263116 - Balloon-Assisted Maturation of Autogenous Arteriovenous Fistulae N/A
Completed NCT05081648 - Must Cannulation Technique of Vascular Access in Patients Undergoing Haemodialysis: Contributions for a Safe Nursing Intervention N/A
Recruiting NCT06454396 - Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure
Not yet recruiting NCT05096416 - Three-dimensional (3D) Printed Hemodialysis Vascular Model N/A